insights_auto
Why is GNMSF down 2.39%?
Dive Deeperchevron_right
GNMSF:OTCMKTS
Genmab A/S
$ 367.00
arrow_downward
-2.39%(-9.00) 1D
10-р сарын 9, 10:28:36 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GNMSF...
Open
$ 367.00
High
$ 367.00
Low
$ 367.00
Mkt. cap
22.49 тэрбум
Avg. vol.
1.37 мян
Volume
52.00
52-wk high
$ 396.97
52-wk low
$ 232.50
Beta
0.73
Shares outstanding
62.41 сая
No. of employees
3 мян
Open
$ 367.00
High
$ 367.00
Low
$ 367.00
Mkt. cap
22.49 тэрбум
Avg. vol.
1.37 мян
Volume
52.00
52-wk high
$ 396.97
52-wk low
$ 232.50
Beta
0.73
Shares outstanding
62.41 сая
No. of employees
3 мян
News stories
From web sources and news partners
Investing.com
·
2 өдрийн өмнө
H.C. Wainwright raises Genmab stock price target on positive trial data
Fierce Pharma
·
3 өдрийн өмнө
AbbVie, Genmab score first-line DLBCL win for Epkinly, teeing up challenge to Roche's Polivy
TradingView
·
3 өдрийн өмнө
European shares gain as Genmab jumps, bond yields retreat
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3.12 мян
Founded1998 оны 6-р сарын 11
Headquarters-
Sector-
Websitegenmab.com